Celldex Therapeutics Stock Price

-1.75 (-4.03%)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Celldex Therapeutics Inc CLDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.75 -4.03% 41.63 16:17:14
Open Price Low Price High Price Close Price Prev Close
42.96 41.334 43.29 41.63 43.38
Bid Price Ask Price Spread News
41.15 44.00 2.85 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,924 464,914 $ 42.17 $ 19,607,026 - 9.59 - 46.4186
Last Trade Time Type Quantity Stock Price Currency
16:09:05 1 $ 42.27 USD


Draw Mode:

Celldex Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.93B 46.46M 46.23M $ 7.42M $ - -2.17 -22.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 839.00k 16.50%

more financials information »

Celldex Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLDX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week39.3844.9639.3843.33600,8152.255.71%
1 Month34.9046.418628.3040.441,475,7976.7319.28%
3 Months30.4246.418623.950135.74849,93011.2136.85%
6 Months19.4946.418615.3730.05765,23022.14113.6%
1 Year10.8046.41869.5923.33713,02730.83285.46%
3 Years0.49646.41860.178.10999,97841.138,293.15%
5 Years4.6946.41860.174.951,386,12236.94787.63%

Celldex Therapeutics Description

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Your Recent History
Celldex Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.